Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer

dc.contributor.authors	Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO
dc.date.accessioned	2020-02-27T08:41:21Z
dc.date.available	2020-02-27T08:41:21Z
dc.date.issued	2014
dc.identifier.citation	Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO (2014). Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Asian Pac J Cancer Prev, 15(17), 23-7119
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66722
dc.title	Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer
dc.identifier.volume	15(17)
dc.identifier.startpage	7119
dc.identifier.endpage	23
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Asian Pac J Cancer Prev
dc.contributor.author	Bayoğlu, İbrahim Vedat